1. Home
  2. WKHS vs LPCN Comparison

WKHS vs LPCN Comparison

Compare WKHS & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Workhorse Group Inc.

WKHS

Workhorse Group Inc.

HOLD

Current Price

$3.79

Market Cap

17.4M

ML Signal

HOLD

Logo Lipocine Inc.

LPCN

Lipocine Inc.

HOLD

Current Price

$2.36

Market Cap

19.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WKHS
LPCN
Founded
2007
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.4M
19.1M
IPO Year
2008
2011

Fundamental Metrics

Financial Performance
Metric
WKHS
LPCN
Price
$3.79
$2.36
Analyst Decision
Hold
Hold
Analyst Count
1
1
Target Price
$21.00
N/A
AVG Volume (30 Days)
266.5K
187.9K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
86.92
46.18
EPS
N/A
N/A
Revenue
$763,173.00
$1,976,677.00
Revenue This Year
$89.23
N/A
Revenue Next Year
$28.84
$92.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$1.81
52 Week High
$11.80
$12.37

Technical Indicators

Market Signals
Indicator
WKHS
LPCN
Relative Strength Index (RSI) 61.71 34.20
Support Level $3.22 $2.20
Resistance Level $4.26 $2.50
Average True Range (ATR) 0.44 0.11
MACD 0.08 0.18
Stochastic Oscillator 74.32 49.98

Price Performance

Historical Comparison
WKHS
LPCN

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: